{
    "eu_accel_assess_g": "False",
    "eu_od_number": "__SCRAPER_NOT_FOUND__",
    "active_substance": "Fulvestrant",
    "eu_aut_status": [
        {
            "value": "ACTIVE",
            "date": "2023-01-09"
        }
    ],
    "eu_brand_name_current": [
        {
            "value": "Faslodex",
            "date": "2023-01-09"
        }
    ],
    "assess_time_days_total": "Not found",
    "ema_od_number": "__SCRAPER_NOT_FOUND__",
    "eu_brand_name_initial": {
        "value": "Faslodex",
        "date": "2023-01-09"
    },
    "assess_time_days_active": "Not found",
    "eu_od_con": "__SCRAPER_NOT_FOUND__",
    "ema_number": "EMEA/H/C/540",
    "atc_code": "L02BA03",
    "eu_nas": "Not available at time of release",
    "ema_number_id": "540",
    "assess_time_days_cstop": "Not found",
    "eu_od_date": "Date is left blank in source",
    "ema_procedure_start_initial": "Date is left blank in source",
    "chmp_opinion_date": "Date is left blank in source",
    "ema_number_certainty": "0.8863636363636364",
    "ec_decision_time_days": "Not found",
    "eu_od_pnumber": "__SCRAPER_NOT_FOUND__",
    "eu_aut_date": "2004-03-10",
    "ema_number_check": true,
    "eu_aut_type_initial": {
        "value": "Not available at time of release",
        "date": "2023-01-09"
    },
    "eu_mah_current": [
        {
            "value": "AstraZeneca AB",
            "date": "2023-01-09"
        }
    ],
    "ema_reexamination": "False",
    "eu_od_sponsor": [
        {
            "value": "__SCRAPER_NOT_FOUND__",
            "date": "2023-01-09"
        }
    ],
    "eu_aut_type_current": [
        {
            "value": "standard",
            "date": "2023-01-09"
        }
    ],
    "eu_mah_initial": {
        "value": "AstraZeneca UK Limited",
        "date": "2023-01-09"
    },
    "eu_orphan_con_current": [
        {
            "value": "__SCRAPER_NOT_FOUND__",
            "date": "2023-01-09"
        }
    ],
    "eu_od_comp_date": "Date is left blank in source",
    "eu_pnumber": "EU/1/03/269",
    "eu_prime_initial": {
        "value": "False",
        "date": "2023-01-09"
    },
    "eu_legal_basis": [
        "__SCRAPER_NOT_FOUND__"
    ],
    "eu_referral": "False",
    "eu_indication_initial": {
        "value": "faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen \n therapy or disease progression on therapy with an antioestrogen.\n",
        "date": "2023-01-09"
    },
    "aut_url": "https://ec.europa.eu/health/documents/community-register/2004/200403107447/dec_7447_en.pdf",
    "eu_od_initial": {
        "value": "__SCRAPER_NOT_FOUND__",
        "date": "2023-01-09"
    },
    "eu_suspension": "False",
    "ema_omar_condition": "__SCRAPER_NOT_FOUND__",
    "smpc_url": "https://ec.europa.eu/health/documents/community-register/2004/200403107447/anx_7447_en.pdf",
    "ema_rapp": "__SCRAPER_NOT_FOUND__",
    "omar_url": "404_url_not_found",
    "epar_url": "https://www.ema.europa.eu/documents/assessment-report/faslodex-epar-public-assessment-report_en.pdf",
    "eu_procedures_todo": [
        {
            "eu_referral": false,
            "eu_suspension": false
        }
    ],
    "eu_atmp": "Not available at time of release",
    "ema_corapp": "__SCRAPER_NOT_FOUND__",
    "odwar_url": "404_url_not_found",
    "orphan_status": "h",
    "eu_med_type": "small molecule"
}